Investigation of clusters of adverse reproductive outcomes, an overview

European Journal of Epidemiology

Volumn 15, Issue 9, 1999, Pages 871-875

  De Wals, Philippe ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b IL   (United States)

Author keywords

Abnormalities; Cluster; Epidemiology; Investigation; Reproduction

Indexed keywords

CHRONIC DISEASE; CLUSTER ANALYSIS; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PUBLIC HEALTH; REPRODUCTION; STATISTICAL ANALYSIS;

ABNORMALITIES; CLINICAL PROTOCOLS; CLUSTER ANALYSIS; COMMUNICATION; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH EDUCATION; HUMANS; MASS MEDIA; MATERNAL EXPOSURE; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PUBLIC RELATIONS;

EID: 0032744010     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007638413985     Document Type: Conference Paper

References (40)

1. Dolk H, De Wals P, Gillerot Y, et al. Heterogeneity of neural tube defects in Europe: The significance of site of defect and presence of other major anomalies to geographic differences in prevalence. Teratology 1991; 44: 547-559.
2. Park CH, Stewart W, Khoury MJ, et al. Is there etiologic heterogeneity between upper and lower neural tube defects? Am J Epidemiol 1992; 136: 1493-1501.
3. Shaw GM, Jensvold NG, Wasserman CR, et al. Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-1987. Teratology 1994; 49: 143-149.
4. Blatter BM, Lafeber AB, Peters PWJ, et al. Heterogeneity of spina bifida. Teratology 1997; 55: 224-230.
5. Keeling JW, Kjaer I. Diagnostic distinction between anencephaly and amnion rupture sequence based on skeletal analysis. J M Genet 1994; 31: 823-829.
6. Ou CY, Stevenson RE, Brown VK, et al. 5,10-methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63: 610-614.
7. Molloy AM, Daly S, Mills JL, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet 1997; 349: 1591-1593.
8. Lindhout D, Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet 1986; i: 1392-1393.
9. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324: 674-677.
10. Fraser CF, Lytwyn A. Spectrum of anomalies in the Meckel syndrome, or: "Maybe there is a malformation syndrome with at least one constant anomaly". Am J Med Genet 1981; 9: 67-73.
11. Shaw GM, Malcoe LH. Residential mobility during pregnancy for mothers of infants with or without congenital cardiac anomalies. Arch Environ Health 1991; 46: 310-312.
12. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 1941; 3: 35-46.
13. Harada Y, Noda K. How it came about the finding of methyl mercury poisoning in Minamata district. Cong Anom 1988; 28 (Suppl): 59-69.
14. Mc Bride WG. Thalidomide and congenital abnormalities. Lancet 1961; ii: 1358.
15. Lenz W. Thalidomide and congenital abnormalities. Lancet 1962; i: 45.
16. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 284: 878-881.
17. Whorton D, Krauss RM, Marshall S, et al. Infertility in male pesticide workers. Lancet 1977; ii: 1259-1261.
18. Fleming LE, Ducatman AM, Shalat SL. Disease clusters: a central and ongoing role in occupational health. J Occup Med 1991; 33: 818-825.
19. Warner SC, Aldrich TE. The status of cancer cluster investigations undertaken by state health departments. Am J Public Health 1988; 78: 306-307.
20. Bender AP, Williams AN, Johnson RA, et al. Appropriate public health responses to clusters: The art of being responsibly responsive. Am J Epidemiol 1990; 132 (Suppl 1): S48-S52.
21. Devier JR, Brownson RC, Bagby JR, et al. A public health response to cancer clusters in Missouri. Am J Epidemiol 1990; 132 (Suppl 1): S23-S31.
22. Fiore BH, Hanrahan LP, Anderson HA. State health department response to disease cluster reports: A protocol for investigation. Am J Epidemiol 1990; 132 (Suppl 1): S14-S22.
23. California Department of Health Services. Investigating non-infectious disease clusters. California Department of Health Services, Environmental Health Investigations Branch, Emeryville, 1990.
24. Centers for Disease Control. Guidelines for investigating clusters of health events. MMWR 1990; 39 (No RR-11): 1-23.
25. King WD, Darlington GA, Kreiger N, et al. Response of a cancer registry to reports of disease clusters. Eur J Cancer 1993; 29A: 1414-1418.
26. Gardner MJ. Approaches to investigating clusters: By example, childhood leukaemia near Sellafield. Soz Präventivmed 1991; 36: 276-278.
27. Frumkin H, Kantrowitz W. Cancer clusters in the workplace: An approach to investigation. J Occup Med 1987; 29: 949-952.
28. Abenhaim L, Lert F. Methodological issues for the assessment of clusters of adverse pregnancy outcomes in the workplace: The case of video display terminal users. J Occup Med 1991; 33: 1091-1096.
29. Fleming LE, Ducatman AM, Shalat SL. Disease clusters in occupational medecine: A protocol for their investigation in the workplace. Am J Indus Med 1992; 22: 33-47.
30. Jacquez GM, Grimson R, Waller LA, et al. The analysis of disease clusters, Part II: Introduction to techniques. Infect Control Hosp Epidemiol 1996; 17: 385-397.
31. Aldrich TE, Drane W, Griffith J. Disease clusters. In: Aldrich TE, Griffith J (eds), Environmental epidemiology and risk assessment. New York: Van Nostrand Reinhold, 1993: 61-82.
32. Jacquez GM, Waller LA, Grimson R, et al. The analysis of disease clusters, Part I: State of the Art. Infect Control Hosp Epidemiol 1996; 17: 319-327.
33. McDiarmid MA, Breysse P, Lees PSJ, et al. Investigation of spontaneous abortion cluster: Lessons learned. Am J Ind Med 1994; 25: 463-475.
34. De Wals P, Niyonsenga T, Laguë J. Investigation d'agrégats d'anomalies de la reproduction: Théorie et pratique. Arch Public Health 1996; 54: 43-58.
35. Wartenberg D, Greenberg M. Solving the cluster puzzle: Clues to follow and pitfalls to avoid. Statistics in Medicine 1993; 12: 1763-1770.
36. Grufferman S. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF (eds), Cancer epidemiology and prevention. Philadelphia: WB Saunders Company, 1982: 744.
37. Chen R, Connelly RR, Mantel N. Analysing post-alarm data in a monitoring system in order to accept or reject the alarm. Statistics in Medicine 1993; 12: 1807-1812.
38. Bannister P. Congenital malformations: Preliminary report of an investigation of reduction deformities of the limbs, triggered by a pilot surveillance system. Can Med Assoc J 1970; 103: 466-473.
39. Brisson C, Laliberté D, Poulin M. Prévalence des anomalies congénitales sévères et investigation d'un agrégat d'anomalies ano-rectales - Région de Trois-Rivières - 1985-1989. Trois-Rivières (Québec): Département de santé communautaire, Centre Hospitalier Ste-Marie, 1991: 1-113.
40. Greenberg M, Wartenberg D. Risk perception. Understanding mass media coverage of disease clusters. Am J Epidemiol 1990; 132 (Suppl 1): S192-S195.